| Enbrel (etanercept) / Pfizer, Amgen |
NCT00520572 / 2007-001420-12: A 6-month Randomised, Double-blind, Open Arm Comparator, Phase IIb, With AZD9056, in Patients With Rheumatoid Arthritis (RA) |
|
|
| Completed | 2b | 385 | US, Canada, Europe, RoW | AZD9056, Etanercept, Placebo | AstraZeneca | Rheumatoid Arthritis | | 03/09 | | |
| Completed | 2b | 373 | Europe, RoW | AZD5672, Etanercept, Enbrel, Placebo | AstraZeneca | Rheumatoid Arthritis | 04/09 | 04/09 | | |
NCT00162279: The Study of Abatacept in Combination With Etanercept |
|
|
| Completed | 2 | 141 | US | Abatacept | Bristol-Myers Squibb | Rheumatoid Arthritis | 02/07 | 02/07 | | |
NCT00135720: Study of Etanercept (Enbrel) in the Treatment of Pemphigus Vulgaris |
|
|
| Completed | 2 | 12 | US | Enbrel (Etanercept) | Massachusetts General Hospital, Brigham and Women's Hospital, Stanford University | Pemphigus Vulgaris | | 11/07 | | |
NCT00447265: Etanercept for the Treatment of Lupus Nephritis |
|
|
| Terminated | 2 | 1 | US | Etanercept, Enbrel, Lupus Treatment- Standard of Care, Placebo | National Institute of Allergy and Infectious Diseases (NIAID) | Lupus Nephritis | 03/09 | 03/09 | | |
NCT00298272: Safety and Tolerability of Rituxan With Methotrexate and Etanercept or Methotrexate and Adalimumab in Patients With Active Rheumatoid Arthritis |
|
|
| Terminated | 2 | 54 | US | IDEC-C2B8 (rituximab), Rituxan, Placebo, Methotrexate, Etanercept, Enbrel, Adalimumab, Humira, Methylprednisolone, Folate | Biogen, Hoffmann-La Roche, Genentech, Inc. | Rheumatoid Arthritis | 04/09 | 07/11 | | |
NCT00979771: A Study to Investigate the Ability of GSK706769 to Maintain Clinical Remission After Withdrawal of Enbrel in Rheumatoid Arthritis Patients |
|
|
| Withdrawn | 2 | 0 | Europe | GSK706769, Placebo | GlaxoSmithKline | Arthritis, Rheumatoid | 04/11 | 04/11 | | |
NCT00434850: Peritransplant Deoxyspergualin in Islet Transplantation in Type 1 Diabetes |
|
|
| Completed | 2 | 14 | US | Allogeneic Pancreatic Islet Cells, Deoxyspergualin, Antithymocyte globulin, Daclizumab or basiliximab, Sirolimus, Tacrolimus, Etanercept | National Institute of Allergy and Infectious Diseases (NIAID), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Diabetes Mellitus, Type 1 | 09/11 | 11/13 | | |
| Completed | 2 | 25 | Europe | Etanercept, Enbrel | University of Leeds, National Institute for Health Research, United Kingdom, Pfizer, Clinical Trials Research Unit, Leeds | Lupus Erythematosus, Discoid, Lupus Erythematosus, Cutaneous, Lupus Erythematosus, Chronic Cutaneous | 12/17 | 12/17 | | |
NCT00285233: Delayed Mycophenolate Mofetil in Single-Donor Islet Allotransplantation in Type 1 Diabetes |
|
|
| Completed | 1/2 | 8 | US | Allogeneic islets of Langerhans transplant, Islet transplant | University of Minnesota, Roche Pharma AG, Juvenile Diabetes Research Foundation | Type 1 Diabetes, Hypoglycemia | 09/04 | 03/05 | | |
NCT00888628: Study of Islet Transplantation in Type 1 Diabetic Kidney Transplant Recipients |
|
|
| Completed | 1/2 | 7 | US | Purified Pancreatic Islets, Etanercept | Massachusetts General Hospital, Boston Area Diabetes Endocrinology Research Center (funded by NIDDK) | Diabetes Mellitus, Type I | 08/14 | 08/16 | | |
NCT00784966: Islet After Kidney Transplant for Type 1 Diabetes |
|
|
| Withdrawn | 1/2 | 0 | US | etanercept, Enbrel | Virginia Commonwealth University, University of Miami | Type 1 Diabetes Mellitus | 09/15 | 09/17 | | |
NCT03160001: Niclosamide With Etanercept in Rheumatoid Arthritis |
|
|
| Completed | 1/2 | 110 | RoW | Placebo, Lactose, Niclosamide, Etanercept, Enbrel | Faiq Gorial | Rheumatoid Arthritis (RA) | 08/18 | 12/18 | | |
